Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CLYM | NVCT |
|---|---|---|
| Price | $10.71 | $20.29 |
| Change today | ▲ 0.28% | ▲ 1.30% |
| Market cap | $615.14M | $662.35M |
| Return, 3 months | -22.5% | +6.8% |
| Return, year to date | +167.8% | +168.7% |
| Return, 1 year | +495.0% | +225.7% |
| P/E (TTM) | -13.1 | -15.4 |
| P/B | 2.6 | 73.0 |
| P/E percentile vs own 5y | 24th | 4th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -55.8% | -10.8% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | -27.1% | -233.3% |
| Analyst target vs. price | +162.5% | +69.2% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 30 | 44 |
| 30-day volatility | 69.4% | 62.9% |
| Max drawdown, 1 year | -40.1% | -36.8% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
